Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Cross-Sectional Study

Postural Orthostatic Tachycardia Syndrome and Orthostatic Hypotension Post COVID-19

Author(s): Masoud Eslami, Reza Mollazadeh, Shayan Mirshafiee, Parisa Sehat, Fatemeh Alizadeh, Zahra Emkanjoo, Vahideh Laleh Far and Elnaz Shahmohamadi*

Volume 23, Issue 1, 2023

Published on: 10 August, 2022

Article ID: e100622205846 Pages: 6

DOI: 10.2174/1871526522666220610143504

Price: $65

Open Access Journals Promotions 2
conference banner
Abstract

Background: Novel coronavirus causes coronavirus disease -19 (COVID-19). The hallmark is acute respiratory distress syndrome, but other systems' involvement is less illustrated. Our goal was to evaluate the manifestation of COVID-19 on one of the overlaps of the cardiovascular and nervous system, namely: Postural Orthostatic Tachycardia Syndrome (POTS) and Orthostatic Hypotension (OH).

Methods: This single-center cross-sectional observational study encompassed 60 consecutive patients that were hospitalized and recovered from severe or critical COVID-19. At the time of discharge, Blood Pressure (BP) and Heart Rate (HR) in the supine and upright position (1st, 3rd, 5th and 10th minutes) were measured. Symptomatic patients were reevaluated 2 months later.

Results: The mean age of patients was 56.6 (± 16.2) years and 42 patients were male (70%). The most frequent cardiovascular risk factor was hypertension (35%). OH and POTS were detected in 29(48.3%) and 10(16.7%) patients, respectively, at the time of hospital discharge. The mean age of patients with OH was higher than POTS and POTS was frequent in the elderly. Two months later, among 10 patients with POTS, the sign and symptoms were resolved in 8(80%). Two (20%) patients who still had positive signs and symptoms of POTS were older than 65 years. Among 29 patients with OH, the signs and symptoms were resolved in 26 (89.7%).

Conclusion: In our study, 65% of patients had OH or POTs on the day of hospital discharge; complete recovery is gradual and needs several additional weeks. This is one of the aspects of the entity recently named “Long COVID”.

Keywords: POTS, orthostatic intolerance, COVID-19, syncope, orthostatic hypotension, ARDs.

Graphical Abstract

[1]
Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579(7798): 265-9.
[http://dx.doi.org/10.1038/s41586-020-2008-3] [PMID: 32015508]
[2]
Coronavirus disease (COVID-2019) situation reports. Available online: https://www.who.int/publications/m/item/weekly-epidemiolo-gical-update-on-covid-19-18-january-2022
[3]
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382(18): 1708-20.
[http://dx.doi.org/10.1056/NEJMoa2002032] [PMID: 32109013]
[4]
Shirazi S, Mami S, Mohtadi N, et al. Sudden cardiac death in COVID-19 patients, a report of three cases. Future Cardiol 2021; 17(1): 113-8.
[http://dx.doi.org/10.2217/fca-2020-0082] [PMID: 32615807]
[5]
Laleh Far V, Mehrakizadeh A, Eslami M, Shirazi S, Mohammadi M, Mollazadeh R. Electrocardiography Holter monitoring in critically ill patients with coronavirus disease 2019 (COVID-19). Pol Arch Intern Med 2020; 130(11): 1010-2.
[6]
Galeotti C, Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol 2020; 16(8): 413-4.
[http://dx.doi.org/10.1038/s41584-020-0448-7] [PMID: 32499548]
[7]
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17(5): 259-60.
[http://dx.doi.org/10.1038/s41569-020-0360-5] [PMID: 32139904]
[8]
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell 2020; 183(1): 16-27.e1.
[http://dx.doi.org/10.1016/j.cell.2020.08.028] [PMID: 32882182]
[9]
Romero-Sánchez C M, Díaz-Maroto I, Fernández-Díaz E, et al. Neurologic manifestations in hospitalized patients with COVID-19. The ALBACOVID registry 2020; 95(8): e1060-70.
[10]
Sheldon RS, Grubb BP II, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm 2015; 12(6): e41-63.
[http://dx.doi.org/10.1016/j.hrthm.2015.03.029] [PMID: 25980576]
[11]
Low PA, Sandroni P, Joyner M, Shen W-K. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol 2009; 20(3): 352-8.
[http://dx.doi.org/10.1111/j.1540-8167.2008.01407.x] [PMID: 19207771]
[12]
Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural orthostatic tachycardia syndrome: JACC focus seminar. J Am Coll Cardiol 2019; 73(10): 1207-28.
[http://dx.doi.org/10.1016/j.jacc.2018.11.059] [PMID: 30871704]
[13]
Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: The Mayo clinic experience. Mayo Clin Proc 2007; 82(3): 308-13.
[http://dx.doi.org/10.1016/S0025-6196(11)61027-6] [PMID: 17352367]
[14]
Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res 2020; 30(5): 449-51.
[http://dx.doi.org/10.1007/s10286-020-00727-9] [PMID: 32880754]
[15]
Kanjwal K, Jamal S, Kichloo A, Grubb BP. 2019 Infection. J Innov Card Rhythm Manag 2020; 11(11): 4302-4.
[http://dx.doi.org/10.19102/icrm.2020.111102] [PMID: 33262898]
[16]
Shen WK, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol 2017; 70(5): e39-e110.
[http://dx.doi.org/10.1016/j.jacc.2017.03.003] [PMID: 28286221]
[17]
Coromilas EJ, Kochav S, Goldenthal I, et al. Arrhythm electrophysiol. Circulation 2022.
[18]
Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA 2020; 324(17): 1723-4.
[http://dx.doi.org/10.1001/jama.2020.19719] [PMID: 33031513]
[19]
Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med 2021; 268: 113426.
[http://dx.doi.org/10.1016/j.socscimed.2020.113426] [PMID: 33199035]
[20]
Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses 2020; 144: 110055.
[http://dx.doi.org/10.1016/j.mehy.2020.110055] [PMID: 32758891]
[21]
Olshansky B, Cannom D, Fedorowski A, et al. Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment. Prog Cardiovasc Dis 2020; 63(3): 263-70.
[http://dx.doi.org/10.1016/j.pcad.2020.03.010] [PMID: 32222376]
[22]
Shaw BH, Stiles LE, Bourne K, et al. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med 2019; 286(4): 438-48.
[http://dx.doi.org/10.1111/joim.12895] [PMID: 30861229]
[23]
Goldstein DS. The possible association between COVID-19 and postural orthostatic tachycardia syndrome. Heart Rhythm 2021; 18(4): 508-9.
[24]
Fu Q, Vangundy TB, Galbreath MM, et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 2010; 55(25): 2858-68.
[http://dx.doi.org/10.1016/j.jacc.2010.02.043] [PMID: 20579544]
[25]
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020; 92(6): 552-5.
[http://dx.doi.org/10.1002/jmv.25728] [PMID: 32104915]
[26]
Bougakov D, Podell K, Goldberg E. Multiple neuroinvasive pathways in COVID-19. Mol Neurobiol 2021; 58(2): 564-75.
[PMID: 32990925]

Rights & Permissions Print Cite
Article Metrics
36
2
Wayfinder Image
Open Access Journals Promotions
World AIDS Day
© 2024 Bentham Science Publishers | Privacy Policy